Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

GM.CD40L cell vaccine

Known as: GM.CD40L 
A cell-based vaccine composed of irradiated tumor cells transduced with granulocyte-macrophage colony-stimulating factor (GM-CSF) and CD40-ligand… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The GM.CD40L vaccine, which recruits and activates dendritic cells, migrates to lymph nodes, activating T cells and leading to… 
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2016
2016
9037Background: Our GM.CD40L vaccine (an allogeneic tumor cell-based vaccine generated from human bystander cell line) recruits… 
2013
2013
3091 Background: Our GM.CD40L vaccine (an allogeneic tumor cell-based vaccine generated from human bystander cell line) recruits… 
2010
2010
2608 Background: A phase I study showed that vaccination of cancer patients with irradiated autologous tumor cells and GM.CD40L… 
2008
2008
Drs Kobayashi and colleagues are correct in pointing out that patient selection, sample size, heterogeneity of patient… 
2006
2006
BackgroundSignificant antitumor T-cell responses are generated in vitro when human lymphocytes are stimulated with autologous… 
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5